The major finding of the present study is that the estimated rate of tumor recurrence at 5 years was 0 % (corresponding to recurrence-free survival of 100 %) in patients with AFP levels <100 ng/ml and with a tumor burden within the limits of either the UCSF or Up-to-7 criteria. The gene discussed is AFP; the disease is neoplasm.